Status:

COMPLETED

A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest

Lead Sponsor:

Scios, Inc.

Conditions:

Heart Failure, Congestive

Heart Decompensation

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to assess the safety and efficacy of two doses of intravenous NATRECOR® hBNP (a recombinant form of the natural human peptide normally secreted by the heart) versus place...

Detailed Description

Human studies reported by SJ Holmes et al, 1993, AM Richards et al, 1993 and M. Yoshimara et al, 1991 show that administration of externally produced hBNP produces vasodilation; antagonism of the horm...

Eligibility Criteria

Inclusion

  • History of chronic congestive heart failure (CHF)
  • symptomatic, decompensated CHF for which intravenous therapy is deemed appropriate for the hospitalized patient
  • documentation of pulmonary capillary wedge pressure (PCWP) \>= 18 mm Hg, Cl \<= 2.7 mL/min/m² and systolic blood pressure \>= 90 mm Hg with consistent baseline hemodynamic measurements.

Exclusion

  • Had a myocardial infarction within the previous 48 hours or unstable angina
  • stroke within the previous 3 months or other evidence of significantly compromised central nervous system perfusion
  • has significant valvular stenosis hypertrophic, restrictive or obstructive cardiomyopathy, constrictive pericarditis, primary pulmonary hypertension, biopsy-proven active myocarditis, or complex congenital heart disease
  • receiving ongoing treatment with an intravenous vasostrictive agent for this episode of decompressed CHF that could not be discontinued for an appropriate washout period to permit the reassessment of baseline hemodynamic and clinical status prior to initiating drug study
  • clinical status so unstable that the subject can not tolerate placement of a Swan-Ganz catheter.

Key Trial Info

Start Date :

October 1 1996

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 1997

Estimated Enrollment :

127 Patients enrolled

Trial Details

Trial ID

NCT00288730

Start Date

October 1 1996

End Date

August 1 1997

Last Update

June 10 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest | DecenTrialz